Pharmaceutical Technology on MSN
Eli Lilly keeps up ophthalmic gene therapy push with $475m MeiraGTx deal
MeiraGTx’s AAV-AIPL1 has already led to vision gains in blind children, as regulatory submissions for the gene therapy close ...
In a world-first trial, scientists used a one-off CRISPR gene edit to switch off a liver “fat brake” gene, slashing stubborn ...
A new gene-editing technique enables the correction of multiple genetic mutations simultaneously, transforming the prospects ...
More research into crop variety development is using gene editing. Canada’s regulatory approach to gene editing will help ...
Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today announced it has entered into a patent license agreement with Shandong ...
From revolutionary CRISPR treatment to heavy drinking dangers, here's what you need to know about the latest health research.
Researchers from Skoltech, the University of Potsdam, and the Massachusetts Institute of Technology have discovered a ...
An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.
MeiraGTx Holdings has signed a deal with Eli Lilly , potentially worth over $475 million, granting the pharma giant rights to ...
Explore CRISPR technology explained, gene editing science, DNA modification, and genetic engineering ethics—discover how ...
A new study by researchers at the Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, has found that some ...
Police in Las Vegas say help from Calgary police has aided them in identifying a victim of an apparent homicide almost 50 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results